Stock MSM MASSMEDICA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Massmedica S.A.

Equities

MSM

PLMSMDC00018

End-of-day quote Warsaw S.E.
Other stock markets
 23:00:00 25/06/2024 BST 		5-day change 1st Jan Change
3.78 PLN -7.35% Intraday chart for Massmedica S.A. -6.44% +53.66%
05-15 Massmedica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-14 Massmedica S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 8.404 20.53 12.07 8.452 5.941
Enterprise Value (EV) 1 9.854 21.24 14.96 12.17 10.65
P/E ratio 19.7 x 34.1 x 34.6 x 20.6 x 19.1 x
Yield - - - - -
Capitalization / Revenue 0.45 x 1.13 x 0.56 x 0.34 x 0.23 x
EV / Revenue 0.53 x 1.17 x 0.69 x 0.49 x 0.4 x
EV / EBITDA 8.69 x 17.5 x 14.5 x 9.59 x 7.74 x
EV / FCF 19 x 20.6 x -7.69 x -42.8 x -2.47 x
FCF Yield 5.26% 4.84% -13% -2.34% -40.6%
Price to Book 2.06 x 4.81 x 2.61 x 1.8 x 1.25 x
Nbr of stocks (in thousands) 2,415 2,415 2,415 2,415 2,415
Reference price 2 3.480 8.500 5.000 3.500 2.460
Announcement Date 30/06/20 31/05/21 27/05/22 31/05/23 21/05/24
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 19.5 18.76 18.19 21.61 24.83 26.36
EBITDA 1 1.17 1.134 1.212 1.03 1.269 1.375
EBIT 1 0.7034 0.6939 0.8311 0.65 0.882 0.8951
Operating Margin 3.61% 3.7% 4.57% 3.01% 3.55% 3.4%
Earnings before Tax (EBT) 1 0.6091 0.5803 0.7777 0.4955 0.5789 0.4983
Net income 1 0.4274 0.4266 0.6023 0.349 0.4097 0.3117
Net margin 2.19% 2.27% 3.31% 1.61% 1.65% 1.18%
EPS 2 0.1770 0.1767 0.2494 0.1445 0.1696 0.1291
Free Cash Flow 1 -1.842 0.5187 1.029 -1.946 -0.2843 -4.318
FCF margin -9.45% 2.77% 5.66% -9% -1.15% -16.38%
FCF Conversion (EBITDA) - 45.76% 84.94% - - -
FCF Conversion (Net income) - 121.59% 170.87% - - -
Dividend per Share - - - - - -
Announcement Date 30/06/20 30/06/20 31/05/21 27/05/22 31/05/23 21/05/24
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.71 1.45 0.72 2.88 3.72 4.71
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.6071 x 1.28 x 0.5911 x 2.797 x 2.931 x 3.422 x
Free Cash Flow 1 -1.84 0.52 1.03 -1.95 -0.28 -4.32
ROE (net income / shareholders' equity) 16.3% 11% 14.4% 7.85% 8.8% 6.78%
ROA (Net income/ Total Assets) 3.75% 2.92% 3.46% 2.6% 3.17% 3.06%
Assets 1 11.39 14.59 17.38 13.43 12.92 10.18
Book Value Per Share 2 1.510 1.690 1.770 1.910 1.940 1.970
Cash Flow per Share 2 0.2000 0.0600 0.0500 0.0500 0.0500 0.0200
Capex 1 1.86 - 0.74 0.32 0.12 0.07
Capex / Sales 9.53% - 4.06% 1.47% 0.48% 0.28%
Announcement Date 30/06/20 30/06/20 31/05/21 27/05/22 31/05/23 21/05/24
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. MSM Stock
  4. Financials Massmedica S.A.